AUVI-Q Hold Time Changes to 2 Seconds
Kaléo recently announced that they changed the hold time of their AUVI-Q epinephrine auto-injectors. They changed the time from 5 seconds to 2 seconds.
Food Allergy News and Research
Possible Epinephrine Nasal Spray May Offer New Option for Those With Food Allergies
INSYS Therapeutics, Inc., announced today that it has started a proof-of-concept study of two formulations of epinephrine nasal spray for the treatment of anaphylaxis, or severe allergic reaction, with the enrollment of the first patient.
Report: 150% Rise in ER Visits for Severe Allergic Reactions Among Children
The Blue Cross Blue Shield Association (BCBSA) released a report called Childhood Allergies in America. The study showed that allergy rates among children increased from 2010 to 2016. The study looked at about 9.6 million U.S. with health insurance, ages 18 and younger. It found that 18 percent of these children have allergies. They looked at anaphylaxis (a severe allergic reaction), dermatitis (inflamed skin or skin rash) and rhinitis (runny, stuffy nose).
Patients Taking Lower Maintenance Doses of Peanut Oral Immunotherapy May Still Achieve Desensitization
Oral immunotherapy (OIT) is a treatment that could potentially help peanut allergic patients achieve desensitization, but some patients are unable to tolerate maintenance doses that are large enough to facilitate unlimited peanut consumption.
Folic Acid Exposure in Utero Is Associated With Development of Food Allergy
Research being presented at the 2018 American Academy of Allergy, Asthma & Immunology (AAAAI) and World Allergy Organization (WAO) Joint Congress suggests that folic acid exposure in utero could have an effect on whether children develop food allergy.
AllergyEats Announces 2018 Top 10 Allergy-Friendly Restaurants Chains
AllergyEats, a popular guide to allergy-friendly restaurants, has announced its 2018 choices for the Top 10 Most Allergy-Friendly Restaurant Chains.
New Research on Growing Issue of Red Meat Allergy
Kids With Food Allergies is sharing this press release from the 2018 AAAAI/WAO Joint Congress to bring you the latest research news quickly. Three studies were presented about Alpha Gal or Red Meat Allergy.
Research Suggests Eosinophilic Esophagitis Is a Late Manifestation of the Atopic March
The atopic march describes how patients who have an allergic disease are more likely to develop another or multiple allergic diseases in their lifetime. This progression commonly starts with eczema in infancy and can develop into food allergy, asthma or hay fever in childhood. Now, new research being presented at the Joint Congress provides evidence that EoE is a late but probable part of this disease progression.
New Study Looks at Causes and Outcomes of Anaphylaxis in Children
Data presented at the 2018 AAAAI/WAO Joint Congress found that reactions to peanut were the most common cause of anaphylaxis in pediatric intensive care units. Food induced anaphylaxis should be considered a serious medical condition and aggressively prevented and treated.
Children With Milk Allergy Tend to be Smaller Than Their Peers
A study presented at the 2018 AAAAI/WAO Joint Congress found that cow’s milk allergy may negatively affect growth in children up to 12 years old.
Proposed SNAP Food Boxes Could Create Challenges for Families With Food Allergies
As part of a budget plan for 2019, the White House is proposing cutting the value of these cards in half. They want to replace the other half with what it calls “America’s Harvest Box.” This box would have “100 percent U.S. grown and produced food,” made up of staple food items.
Treatment for Milk Allergy Shows Positive Results in Clinical Trial
DBV Technologies today announced preliminary results from Part B, or Phase II, of a Phase I/II study evaluating the efficacy and safety of three dose regimens of Viaskin Milk (150 µg, 300 µg, 500 µg) in 198 patients for the treatment of IgE-mediated cow's milk protein allergy (CMPA). The MILES (Milk Efficacy and Safety) study was designed to determine a safe and effective dose in two age groups.
Two Peanut Allergy Treatment Trials Move Forward
Kids With Food Allergies is sharing these press releases from Aimmune Therapeutics and DBV Technologies to bring you the latest research news quickly. [PRESS RELEASE] Aimmune Therapeutics’ Pivotal Phase 3 PALISADE Trial of AR101 Meets Primary Endpoint in Patients With Peanut Allergy BRISBANE, Calif.– (BUSINESS WIRE) – Feb. 20, 2018 – Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced...
What Are Your Options for Epinephrine Auto-Injectors?
Epinephrine is a lifesaving medicine for people with severe allergies. It is important to discuss with your doctor about what is the most appropriate prescription for your family. You may also need to find out which options your insurance provider prefers. This will affect your out-of-pocket costs. Each device has its own unique set of instructions. Understanding those differences is important so that you get the device you want and you know how to use it. Pharmacists must follow state and...
How to Talk With Your Child About the Peter Rabbit Movie
The movie "Peter Rabbit" depicts a scene some families managing food allergies might find alarming. Peter and the other rabbits intentionally attack Mr. McGregor with his known food allergen causing him to have a serious allergic reaction, called anaphylaxis (anna-fih-LACK-sis).